432.84
-7.59
(-1.72%)
At close: April 18 at 3:00:02 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,961,331.17
1,650,211.80
1,216,017.97
828,687.88
479,436.31
Cost of Revenue
543,221.35
474,179.43
350,165.53
252,843.20
142,127
Gross Profit
1,418,109.81
1,176,032.37
865,852.44
575,844.68
337,309.31
Operating Expense
680,291.33
597,831.85
474,083.45
375,192.18
214,269.63
Operating Income
737,818.48
578,200.53
391,768.99
200,652.50
123,039.68
Net Non Operating Interest Income Expense
1,239.26
594.48
1,514.39
361.01
229.49
Pretax Income
728,984.27
596,367.79
395,131.82
221,552.76
121,213.99
Tax Provision
81,366.76
74,237.52
54,975.04
26,701.69
17,019.14
Net Income Common Stockholders
658,823.62
533,924.24
358,019.71
207,921.10
110,775.78
Basic EPS
6.82
5.54
3.71
2.20
1.53
Diluted EPS
6.76
5.46
3.66
2.19
1.53
Basic Average Shares
96,405.81
96,292.31
96,492.30
94,509.59
72,353.55
Diluted Average Shares
97,427.64
97,751.28
97,948.79
95,105.86
72,353.55
Total Operating Income as Reported
734,711.90
600,414.70
396,988.40
222,501.62
119,445.86
Total Expenses
1,223,512.69
1,072,011.28
824,248.98
628,035.39
356,396.63
Net Income from Continuing & Discontinued Operation
658,823.62
533,924.24
358,019.71
207,921.10
110,775.78
Normalized Income
681,104.60
537,578.94
373,703.86
197,907.48
113,633.73
Interest Income
10,763.38
4,605.68
3,190.11
2,157.31
1,206.47
Interest Expense
2,179
3,688.67
1,451.71
1,626.15
830.97
Net Interest Income
1,239.26
594.48
1,514.39
361.01
229.49
EBIT
731,163.27
600,056.46
396,583.53
223,178.91
122,044.96
EBITDA
731,163.27
664,891.64
444,845.23
256,620.72
142,047.47
Reconciled Cost of Revenue
543,221.35
474,179.43
350,165.53
252,843.20
142,127
Reconciled Depreciation
--
64,835.18
48,261.70
33,441.81
20,002.51
Net Income from Continuing Operation Net Minority Interest
658,823.62
533,924.24
358,019.71
207,921.10
110,775.78
Total Unusual Items Excluding Goodwill
-25,080.37
-4,174.32
-18,218.97
11,385.84
-3,324.77
Total Unusual Items
-25,080.37
-4,174.32
-18,218.97
11,385.84
-3,324.77
Normalized EBITDA
756,243.64
669,065.96
463,064.20
245,234.88
145,372.24
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,799.39
-519.63
-2,534.82
1,372.23
-466.82
12/31/2020 - 1/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688016.SS Shanghai MicroPort Endovascular MedTech Co., Ltd.
86.56
-0.33%
6609.HK Shanghai HeartCare Medical Technology Corporation Limited
26.450
-6.54%
300760.SZ Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
217.08
-2.07%
BSX Boston Scientific Corporation
95.12
-0.14%
MDT Medtronic plc
82.60
-0.12%